Crowley, Fionnuala
Mihalopoulos, Meredith
Gaglani, Simita
Tewari, Ashutosh K.
Tsao, Che-Kai
Djordjevic, Miroslav
Kyprianou, Natasha
Purohit, Rajveer S. http://orcid.org/0000-0002-5912-8354
Lundon, Dara J. http://orcid.org/0000-0003-4425-3520
Article History
Received: 28 April 2022
Revised: 29 August 2022
Accepted: 12 September 2022
First Online: 19 October 2022
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: AKT certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (e.g., employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received or pending), are the following: AKT has served as a site PI on pharma/industry-sponsored clinical trials from Kite Pharma Inc., Lumicell, Inc., Dendron Pharmaceuticals, LLC, Oncovir Inc., Blue Earth Diagnostics Ltd., RhoVac ApS., Bayer HealthCare Pharmaceuticals Inc., and Janssen Research and Development, LLC; has received research funding (grants) to his institution from DOD, NIH, Axogen, Intuitive Surgical, AMBF and other philanthropy; has served as an unpaid consultant to Roivant Biosciences and advisor to Promaxo; and owns equity in Promaxo. The remaining authors declare no competing interests in relation to the work described.